​The Bone Cancer Research Trust believe collaboration is the key to making progress in research, therefore we are delighted to announce that we are co-funding the EURO EWING Consortium (EEC) in collaboration with Ewing’s Sarcoma Research Trust.

Ewing sarcoma is a rare cancer and so, it is imperative that experts in this field work together to make scientific progress and develop clinical trials, which simply wouldn’t be possible without international collaboration.

The EEC was established in 2013 and is a collaborative group of clinicians, scientists and patient advocates from across Europe and beyond, working together to improve survival and quality of life for patients with Ewing sarcoma. The consortium has been responsible for the development and delivery of two key international trials: EuroEwing2012, which resulted in a new, more effective chemotherapy backbone for European patients and rEECur, which is still underway.

The EEC will focus on developing new international trials and co-ordinating data harmonisation across different countries, developing better treatments, supporting global efforts through collaboration and seeking long-term funding for research.

Dr Zoe Davison, Head of Research, Support and Information at the Bone Cancer Research Trust, said:

We are incredibly excited to be funding the EEC in collaboration with our friends at Ewing’s Sarcoma Research Trust. This funding will ensure the EEC can continue for another year. We believe that, by ensuring the continuation of this consortium we will facilitate new clinical trials, which are essential for getting new and more effective treatments to our patients.